Insulin The Focus At ADA 2012, But Don’t Forget GLP-1s And SGLT-2s

In anticipation of the American Diabetes Conference of 2012, analysts take a look at several categories of drugs that will be playing a major role in the future of diabetes care.

More from Clinical Trials

More from R&D